Total Payments
$4,709
2024 Payments
$960.42
Companies
34
Transactions
169
Medicare Patients
7,343
Medicare Billing
$915,383
Payment Breakdown by Category
Food & Beverage$4,709 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,709 | 169 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| BIOTRONIK INC. | $717.61 | 16 | $0 (2023) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $641.24 | 26 | $0 (2024) |
| Merck Sharp & Dohme LLC | $339.31 | 17 | $0 (2024) |
| Cardiovascular Systems Inc. | $334.51 | 5 | $0 (2018) |
| PFIZER INC. | $244.33 | 18 | $0 (2024) |
| Abbott Laboratories | $219.89 | 5 | $0 (2024) |
| Medtronic Vascular, Inc. | $212.72 | 4 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $196.27 | 10 | $0 (2024) |
| Braemar Manufacturing, LLC | $153.95 | 1 | $0 (2019) |
| Amgen Inc. | $153.63 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $960.42 | 42 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($216.31) |
| 2023 | $1,494 | 65 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($267.27) |
| 2022 | $815.33 | 25 | Stryker Corporation ($149.29) |
| 2021 | $275.64 | 8 | Abbott Laboratories ($135.45) |
| 2019 | $510.83 | 14 | BIOTRONIK INC. ($230.29) |
| 2018 | $574.20 | 14 | Cardiovascular Systems Inc. ($334.51) |
| 2017 | $78.01 | 1 | Medtronic Vascular, Inc. ($78.01) |
All Payment Transactions
169 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $25.87 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/18/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $35.22 | General |
| Category: Narcoplepsy | ||||||
| 12/02/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $25.19 | General |
| Category: Heart Failure | ||||||
| 12/02/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/25/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $22.01 | General |
| Category: Cardiovascular | ||||||
| 11/20/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: Cardiology | ||||||
| 11/12/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $26.53 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/05/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $20.78 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/28/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $24.16 | General |
| Category: Cardiovascular | ||||||
| 10/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: DIABETES | ||||||
| 10/14/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $27.49 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/10/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $17.84 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/03/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $22.91 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/24/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.73 | General |
| Category: Diabetes | ||||||
| 09/13/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $26.89 | General |
| Category: Cardiology | ||||||
| 09/10/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $17.43 | General |
| Category: Heart Failure and Hypertension | ||||||
| 09/09/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $23.63 | General |
| Category: Cardiology | ||||||
| 08/23/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: Cardiology | ||||||
| 08/21/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 08/20/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $40.73 | General |
| Category: Narcoplepsy | ||||||
| 08/16/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $25.09 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/08/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $25.19 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/24/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/15/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $28.24 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/09/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $20.64 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 1,853 | 4,419 | $664,865 | $224,314 |
| 2022 | 23 | 1,830 | 3,344 | $680,962 | $227,578 |
| 2021 | 26 | 1,907 | 4,205 | $710,664 | $250,803 |
| 2020 | 29 | 1,753 | 5,878 | $597,412 | $212,687 |
Total Patients
7,343
Total Services
17,846
Medicare Billing
$915,383
Procedure Codes
108
All Medicare Procedures & Services
108 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 245 | 489 | $120,294 | $49,303 | 41.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 221 | 231 | $84,656 | $32,558 | 38.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 136 | 292 | $72,615 | $28,631 | 39.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 507 | 521 | $106,284 | $28,588 | 26.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 104 | 107 | $61,525 | $18,142 | 29.5% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 45 | 45 | $44,100 | $17,799 | 40.4% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 14 | 22 | $27,478 | $7,993 | 29.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 33 | 43 | $22,102 | $7,461 | 33.8% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 39 | 40 | $25,560 | $7,065 | 27.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 33 | 33 | $10,197 | $4,291 | 42.1% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 45 | 54 | $11,178 | $4,115 | 36.8% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 41 | 62 | $6,944 | $3,911 | 56.3% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 52 | 166 | $11,620 | $3,462 | 29.8% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 46 | 46 | $8,878 | $2,486 | 28.0% |
| 92978 | Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | Facility | 2023 | 23 | 24 | $14,328 | $1,779 | 12.4% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 13 | 16 | $8,368 | $1,431 | 17.1% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 16 | 16 | $3,872 | $1,400 | 36.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 75 | 81 | $4,050 | $933.20 | 23.0% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 39 | 45 | $2,160 | $921.60 | 42.7% |
| J0153 | Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | Office | 2023 | 26 | 1,980 | $7,920 | $809.32 | 10.2% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 68 | 74 | $9,472 | $739.26 | 7.8% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2023 | 16 | 16 | $784.00 | $317.47 | 40.5% |
| 93246 | Heart rhythm recording of continous external ekg over 8-15 days | Office | 2023 | 16 | 16 | $480.00 | $177.44 | 37.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 220 | 416 | $102,336 | $39,755 | 38.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 210 | 216 | $89,856 | $34,504 | 38.4% |
About Dr. Young Lee, MD
Dr. Young Lee, MD is a Cardiovascular Disease healthcare provider based in Escondido, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/13/2007. The National Provider Identifier (NPI) number assigned to this provider is 1285833764.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Young Lee, MD has received a total of $4,709 in payments from pharmaceutical and medical device companies, with $960.42 received in 2024. These payments were reported across 169 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($4,709).
As a Medicare-enrolled provider, Lee has provided services to 7,343 Medicare beneficiaries, totaling 17,846 services with total Medicare billing of $915,383. Data is available for 4 years (2020–2023), covering 108 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Escondido, CA
- Active Since 07/13/2007
- Last Updated 03/07/2023
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1285833764
Products in Payments
- LifeVest (Device) $641.24
- VERQUVO (Drug) $339.31
- Coronary Orbital Atherectomy System (Device) $334.51
- ELIQUIS (Drug) $287.68
- AMVIA EDGE (Device) $238.13
- Cardiac Monitoring Suite (Device) $153.95
- Repatha (Biological) $153.63
- RAVINE LATERAL ACCESS SYSTEM (Device) $149.29
- MitraClip System (Device) $135.45
- Adapta (Device) $134.71
- Orsiro Mission (Device) $131.89
- WATCHMAN Access System (Device) $122.12
- LEQVIO (Drug) $114.69
- WAKIX (Drug) $103.75
- XARELTO (Drug) $103.05
- Assure WCD (Device) $96.41
- ENTRESTO (Drug) $81.58
- Resolute (Device) $78.01
- ZIO XT Patch (Device) $72.44
- JARDIANCE (Drug) $68.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Escondido
Navinder Sawhney, Md, MD
Cardiovascular Disease — Payments: $126,745
Cardiovascular Disease $126,745
Dr. Robert Orr, Md, MD
Cardiovascular Disease — Payments: $22,593
Cardiovascular Disease $22,593
Mikhail Malek, M.d, M.D
Cardiovascular Disease — Payments: $17,358
Cardiovascular Disease $17,358
Roger Acheatel, M.d, M.D
Cardiovascular Disease — Payments: $11,818
Cardiovascular Disease $11,818
Hamed Bayat, M.d, M.D
Cardiovascular Disease — Payments: $9,746
Cardiovascular Disease $9,746
Dennis Leahy, M.d, M.D
Cardiovascular Disease — Payments: $6,956
Cardiovascular Disease $6,956